financetom
Business
financetom
/
Business
/
PGIM Fixed Income completes private purchase of $500 mln loan from Affirm
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PGIM Fixed Income completes private purchase of $500 mln loan from Affirm
Dec 3, 2024 6:26 AM

NEW YORK, Dec 3 (Reuters) - Prudential Financial's ( PRU )

PGIM Fixed Income has completed the private purchase of

$500 million worth of loans from buy-now-pay-later firm Affirm

Holdings ( AFRM ), the two companies said on Tuesday.

The transaction deepens Affirm's partnership with PGIM Fixed

Income, which manages an asset-based finance business with more

than $120 billion in assets under management across public and

private securitized credit

PGIM Fixed Income had also invested in Affirm's assets in

the past through asset-backed securitizations, the statement

said.

PGIM Fixed Income has originated multiple billions of

dollars of asset-backed financing this year and expects to

nearly triple the amount next year, Edwin Wilches, Managing

Director and Co-Head of Securitized Products at PGIM Fixed

Income, told Reuters.

"The economy is growing, need for financing is growing and

the traditional lender banks have less appetite or have less

ability to do (these kinds of financing). So there's a gap," he

said.

Other factors that are helping to grow the ABF market for

fund managers is more flows into fixed income markets as yields

are higher, insurance companies are growing and diversifying,

while additional demand is coming from pensions.

"We see U.S. pension funds being attracted to ABF deals as

they provide attractive spreads while achieving a

diversification benefit away from their pre-existing public and

private corporate-focused portfolios," Wilches said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IDEAYA Biosciences Exercises Option to Develop Biocytogen's Potential Cancer Treatment
IDEAYA Biosciences Exercises Option to Develop Biocytogen's Potential Cancer Treatment
Nov 11, 2024
06:59 AM EST, 11/11/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) has exercised its option for an exclusive worldwide license for Biocytogen Pharmaceuticals' IDE034 cancer drug as a development candidate, the companies said Monday. Under agreement between the two companies, Biocytogen will receive fees, regulatory and commercial milestone payments, and royalties totaling $406.5 million. IDEAYA Science Chief Michael White...
Freegold Ventures On Intersections at Golden Summit
Freegold Ventures On Intersections at Golden Summit
Nov 11, 2024
06:53 AM EST, 11/11/2024 (MT Newswires) -- Freegold Ventures Limited ( FGOVF ) earlier Monday announced recent developments from its drilling program in 2024, highlighting four specific holes that were drilled to facilitate additional metallurgical testing. Among highlights, the company said it intersected 3.62 G/T au over 42 metres and 1.23 G/T au over 170.7 metres at Golden Summit. A...
Tesla's Shares Extend Gains Following President-Elect Trump's Victory
Tesla's Shares Extend Gains Following President-Elect Trump's Victory
Nov 11, 2024
06:45 AM EST, 11/11/2024 (MT Newswires) -- Tesla's (TSLA) shares advanced 7% in recent Monday premarket activity, after rising more than 8% on Friday following President-elect Donald Trump's victory in Tuesday's election. Since Trump's victory, hedge funds that had short positions against the EV maker lost at least $5.2 billion between Tuesday and Friday's close, Bloomberg reported Monday, citing calculations...
Market Chatter: Deutsche Bank Fires 111 Senior Managers in Wealth Unit to Cut Costs
Market Chatter: Deutsche Bank Fires 111 Senior Managers in Wealth Unit to Cut Costs
Nov 11, 2024
06:51 AM EST, 11/11/2024 (MT Newswires) -- Deutsche Bank ( DB ) fired 111 senior managers in its retail and private wealth business on Monday, the Financial Times reported, as the company aims to reduce its cost-to-income ratio to between 60% and 65% in 2025. The number of slashed jobs represents 8% of the directors and managing directors in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved